Pulmonary Involvement in Patients with Hematological Malignancies

Editors: Azoulay, Elie (Ed.)

  • Provides detailed information on all relevant aspects of pulmonary involvement in patients with hematological malignancies
  • Leading experts discuss epidemiology, diagnostic strategy, lung infections, non-infectious pulmonary involvement, and treatment
  • Presents invaluable "pearls" relating to each condition
see more benefits

Buy this book

eBook $219.00
price for USA (gross)
  • ISBN 978-3-642-15742-4
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $279.00
price for USA
  • ISBN 978-3-642-15741-7
  • Free shipping for individuals worldwide
  • Online orders shipping within 2-3 days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
About this book

The number of patients treated for hematological malignancies is increasing steadily. To obtain the highest possible cure rates, aggressive treatments have been introduced, including high-dose chemotherapy, stem cell transplantation, and targeted therapies. As a result, overall and disease-free survival rates have improved substantially; however, this has been achieved at the price of life-threatening toxic and infectious complications that chiefly target the lung. This book provides clinicians caring for patients with hematological malignancies with detailed, up-to-date information on all relevant aspects of pulmonary involvement. Individual sections are devoted to epidemiology, diagnostic strategy, lung infections, non-infectious pulmonary involvement, and treatment, including decision making in patients with acute respiratory failure. Each of these sections contains a number of chapters, all written by leading international experts. In addition, the reader’s attention is drawn to important "pearls" relating to each condition.

About the authors

Dr Élie Azoulay is the Assistant Director of the Medical ICU at the Saint-Louis Teaching Hospital, Paris, France. He is a professor of medicine at the Denis Diderot Paris 7 University. From his background as a pulmonologist, Dr Azoulay developed a strong research focus on acute respiratory failure in immunocompromized patients. His PhD work was on respiratory physiology in an experimental model of cancer chemotherapy-related pulmonary toxicity. He has several published clinical research studies on acute respiratory failure in hematology and oncology patients. Also, Dr Azoulay leads a collaborative multicenter group that has performed observational studies, large cohort studies, and randomized controlled trials in cancer patients with ARF. His second major field of interest in clinical research is communication with family members of ICU patients. He constituted a research group in 1997 (the French Famirea Study Group) to evaluate the ability of critical care clinicians to provide effective information to ICU patients and families. Several of his published studies investigated the burden of critical illness in relatives and in ICU clinicians. The group’s major aim is to identify targets for improvement and to test potential interventions in international RCTs in order to advance ICU practices in the field of information and communication. In addition to clinical and research activities, Dr Azoulay teaches pulmonary medicine, critical care medicine, and ethics at the Paris Medical School. He is also associate editor of Intensive Care Medicine, in the editorial board of the American Journal of respiratory and Critical Care medicine, and the chairman of the ethics section of the ESICM. Dr Azoulay is a member of the European board of Pfizer and Gilead.

Reviews

From the reviews:

“This is a detailed, multiauthored review of infectious, inflammatory, and thromboembolic complications in patients with a variety of hematological cancers. … Practitioners with an interest in hematological malignancy and intensivists providing critical care resources for management of these patients are an appropriate audience for this work coming from an international panel of authors, the majority of whom are from France. … This unique book effectively reviews the current therapy, incidence, and outcomes for this complex patient group.” (David J. Dries, Doody’s Review Service, December, 2011)

Table of contents (73 chapters)

  • Managing Patients with Hematological Malignancies for 25 Years

    Schlemmer, Benoit

    Pages 3-4

  • Pulmonary Involvement in Patients with Hematological Malignancies

    Azoulay, Élie

    Pages 5-7

  • Respiratory Infections in Patients with Hematological Malignancies

    Soubani, Ayman O.

    Pages 9-38

  • Epidemiology of Respiratory Events in Patients with HM (Not Including ICU)

    Maschmeyer, Georg

    Pages 41-45

  • Epidemiology of Acute Respiratory Failure in Patients with HM (ICU Only)

    Agustí, Carlos (et al.)

    Pages 47-55

Buy this book

eBook $219.00
price for USA (gross)
  • ISBN 978-3-642-15742-4
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $279.00
price for USA
  • ISBN 978-3-642-15741-7
  • Free shipping for individuals worldwide
  • Online orders shipping within 2-3 days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Pulmonary Involvement in Patients with Hematological Malignancies
Editors
  • Elie Azoulay
Copyright
2011
Publisher
Springer-Verlag Berlin Heidelberg
Copyright Holder
Springer-Verlag Berlin Heidelberg
eBook ISBN
978-3-642-15742-4
DOI
10.1007/978-3-642-15742-4
Hardcover ISBN
978-3-642-15741-7
Edition Number
1
Number of Pages
XIX, 827
Topics